BioXcel Therapeutics, Inc. (BTAI)
2.07
-0.12
(-5.48%)
USD |
NASDAQ |
Dec 11, 16:00
2.09
+0.02
(+0.97%)
After-Hours: 20:00
BioXcel Therapeutics Shareholders Equity (Quarterly): -88.92M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Xilio Therapeutics, Inc. | -8.095M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
| Theriva Biologics, Inc. | 6.738M |
| Oragenics, Inc. | 9.831M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 44.79M |
| Total Liabilities (Quarterly) | 133.71M |
| Debt to Equity Ratio | -1.229 |
| Current Ratio | 1.175 |
| Net Debt Paydown Yield | -2.21% |